A 66-year-old male with GOLD stage III COPD presents for fol…
A 66-year-old male with GOLD stage III COPD presents for follow-up after a recent hospitalization for an exacerbation. He continues to smoke and reports inconsistent inhaler use. His baseline PaO₂ is 54 mmHg on room air, and he has evidence of mild cor pulmonale on echocardiogram. The AGACNP provides education focused on interventions that improve long-term outcomes. Which of the following patient statements demonstrates the most accurate understanding of therapies proven to improve survival in COPD?
Read Details